viernes, 7 de septiembre de 2012

Are Testosterone Drugs the Next Viagra?


Testosterone replacement has long been prescribed for men who suffer from abnormally low levels of the male sex hormone, but overuse can lead to infertility and can even speed the growth of prostate cancer. That hasn’t stopped Michael Murray, a healthy 43-year-old home stager who works in New York and Chicago, from getting frequent testosterone injections to raise his energy level and give his bodybuilding regime a boost. “Am I making a deal with the devil? A little bit, but I have to think about my quality of life,” Murray explains. “It is like I’m in my 20s again.

In what may become one of the most sought-after lifestyle drugs since the introduction of Pfizer’s Viagra 14 years ago, new testosterone drugs from Eli Lilly, Abbott Laboratories, and other drugmakers are hot.


Click sobre imagen para ampliar

Prescriptions for testosterone replacement therapies have more than doubled since 2006 to 5.6 million last year, according to data compiled by Bloomberg. Sales are expected to triple to $5 billion by 2017, forecasts Global Industry Analysts.

.../...

While growing, sales of the drugs aren’t on par with those of erectile dysfunction treatments. The U.S. market for testosterone replacement therapies was $1.6 billion in 2011, according to Bloomberg data. Sales of ED drugs were $5.3 billion, says IMS Health. But new testosterone prescriptions are growing fast, and facilities are opening across the U.S. to meet the demand. Johnny Mitias, an orthopedic surgeon in Mississippi, opened Ageless Men’s Health, a chain of testosterone clinics, in 2007. Mitias says he has 5,000 patients, who each pay $250 a month to receive testosterone injections. He now has 15 offices and plans to double the number next year. (Más)


In what may become one of the most sought-after sex enhancement treatments since the introduction of Viagra 14 years ago, new testosterone drugs from Abbott, Lilly and other drugmakers are in hot demand. Prescriptions for testosterone replacement therapies have more than doubled since 2006 to 5.6 million, according to data compiled by Bloomberg. Sales are expected to triple to $5 billion by 2017, according to Global Industry Analysts Inc.


Click sobre imagen para ampliar

Mas

Asi se promociona:

Comentario de textos (o de textículos): Itnogen

Ver

Testosterone is the New Viagra

Ver Testosterona en PHARMACOSERÍAS


Publicar un comentario